CASEID,PRIMARYID,CASEVERSION,I_F_CODE,EVENT_DT,MFR_DT,INIT_FDA_DT,FDA_DT,REPT_COD,AUTH_NUM,MFR_NUM,MFR_SNDR,LIT_REF,AGE,AGE_COD,AGE_GRP,SEX,E_SUB,WT,WT_COD,REPT_DT,TO_MFR,OCCP_COD,REPORTER_COUNTRY,OCCR_COUNTRY,DRUGNAME,PT,PRIMARYID_OUTC,OUTC_COD,PRIMARYID_RPSR,RPSR_COD,PRIMARYID_THER,DSG_DRUG_SEQ,START_DT,END_DT,DUR,DUR_COD,PRIMARYID_INDI,INDI_DRUG_SEQ,INDI_PT
10022970,100229704,4,F,20140228,20140708,20140319,20140709,EXP,,MW-GILEAD-2014-0096862,GILEAD,,44,YR,,M,Y,40.8,KG,20140709,N,MD,MW,MW,EFAVIRENZ,Death;Immune reconstitution inflammatory syndrome,100229704,HO,,,100229704,1,20140225,,,,100229704,1,HIV infection
10048079,100480795,5,F,20140124,20140804,20140331,20140813,EXP,,GB-VERTEX PHARMACEUTICALS INC-2014-001634,VERTEX,,67,YR,,M,Y,62,KG,20140813,N,CN,GB,GB,EFAVIRENZ,Acute generalised exanthematous pustulosis;Off label use,100480795,HO,,,100480795,1,20140124,20140318,,,100480795,1,Hepatitis C
10051161,100511613,3,F,20140310,20140630,20140401,20140708,EXP,,US-GILEAD-2014-0098078,GILEAD,,57,YR,,F,Y,66,KG,20140708,N,MD,US,US,SUSTIVA,Ammonia abnormal;Ataxia;Dyspnoea;Hepatic encephalopathy;Tremor,100511613,OT,,,100511613,1,20140306,,,,100511613,1,Hepatitis C
10071551,100715513,3,F,20140310,20140916,20140410,20140922,EXP,IT-PVNET-243070,IT-GILEAD-2014-0097683,GILEAD,,37,YR,A,M,Y,,,20140922,N,MD,IT,IT,SUSTIVA,Pruritus generalised;Toxic skin eruption,100715513,OT,,,100715513,1,20140226,20140309,,,100715513,1,HIV infection
10081632,100816323,3,F,,20140717,20140414,20140725,EXP,,AUR-APL-2014-04268,AUROBINDO,,36,YR,,M,N,,,20140724,N,OT,IT,,EFAVIRENZ (EFAVIRENZ),Cardiac failure;Cardiac failure chronic;Congestive cardiomyopathy;Heart transplant,100816323,OT,100816323,FGN,,,,,,,100816323,1,Antiretroviral therapy
10085309,100853092,2,F,20140324,20140717,20140417,20140723,EXP,,US-GILEAD-2014-0099707,GILEAD,,34,YR,,F,Y,,,20140723,N,OT,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion missed,100853092,OT,,,100853092,1,20140228,20140220,,,100853092,1,HIV infection
10150341,101503412,2,F,20140318,20140717,20140502,20140728,EXP,,GB-VERTEX PHARMACEUTICALS INC-2014-002167,VERTEX,,67,YR,,M,Y,62,KG,20140728,N,OT,GB,GB,EFAVIRENZ,Anal abscess;Periorbital oedema;Rash,101503412,HO,,,101503412,1,20140124,20140318,,,101503412,1,Hepatitis C
10167492,101674924,4,F,20140422,20140710,20140512,20140716,EXP,,US-GILEAD-2014-0101624,GILEAD,,23,YR,,F,Y,,,20140716,N,MD,US,US,SUSTIVA,Alanine aminotransferase increased;Aspartate aminotransferase increased,101674924,OT,,,101674924,1,20140407,20140422,,,101674924,1,HIV infection
10182070,101820702,2,F,20140318,20140805,20140520,20140812,EXP,,GB-ROCHE-1398769,ROCHE,,67,YR,,M,Y,62,KG,20140812,N,OT,GB,GB,EFAVIRENZ,Anal abscess;Periorbital oedema;Rash,101820702,HO,,,101820702,1,20140324,20140711,,,101820702,1,Hepatitis C
10182911,101829112,2,F,20140318,20140805,20140516,20140815,EXP,,AUR-APL-2014-05618,AUROBINDO,,67,YR,,M,N,62,KG,20140814,N,OT,GB,,EFAVIRENZ,Anal abscess;Periorbital oedema;Rash;Skin lesion,101829112,OT,101829112,HP,101829112,1,20140122,20140323,,,101829112,1,Hepatitis C
10184789,101847892,2,F,20140325,20140805,20140519,20140925,EXP,,KAD201405-000498,KADMON,,67,YR,,M,N,62,KG,20140919,N,OT,GB,,EFAVIRENZ,Anal abscess;Periorbital oedema;Rash,101847892,OT,101847892,HP,101847892,1,20140122,20140323,,,101847892,1,Hepatitis C
10207459,102074593,3,F,,20140507,20140530,20140815,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-20225124,BRISTOL MYERS SQUIBB,,2,YR,,F,Y,,,20140815,N,CN,US,US,SUSTIVA TABS,Drug resistance,102074593,OT,,,,,,,,,102074593,4,HIV infection
10222240,102222403,3,F,20140326,20140716,20140606,20140722,EXP,,US-VIIV HEALTHCARE LIMITED-A1076059A,GLAXOSMITHKLINE,,23,YR,,F,Y,,,20140826,N,OT,US,US,SUSTIVA,Alanine aminotransferase increased;Aspartate aminotransferase increased;Liver function test abnormal,102222403,OT,,,102222403,1,2012,20140407,,,102222403,1,HIV infection
10234683,102346832,2,F,201403,20140731,20140613,20140808,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-20965414,BRISTOL MYERS SQUIBB,,63,YR,,M,Y,,,20140808,N,OT,US,US,SUSTIVA,Death;Glioblastoma multiforme,102346832,OT,,,,,,,,,102346832,1,HIV infection
10236118,102361184,4,F,20140529,20140714,20140613,20140716,EXP,,KE-GILEAD-2014-0104936,GILEAD,,33,YR,,F,Y,38.4,KG,20140716,N,MD,KE,KE,EFAVIRENZ,Acute psychosis;Cholecystitis;Encephalitis;Malnutrition;Toxoplasmosis,102361184,OT,,,102361184,1,20140528,20140603,,,102361184,1,HIV infection
10248742,102487424,4,F,20140124,20140804,20140620,20140806,EXP,,GB-009507513-1406GBR009389,MERCK,,67,YR,,M,Y,62,KG,20140806,N,CN,US,GB,EFAVIRENZ,Acute generalised exanthematous pustulosis;Off label use,102487424,OT,,,102487424,1,20140124,20140711,,,102487424,1,HIV infection
10250677,102506772,2,F,2012,20140702,20140620,20140710,EXP,,CN-VIIV HEALTHCARE LIMITED-B1005837A,GLAXOSMITHKLINE,"LU WL, SHI PR, XU GY. ONE CASE OF BONE MARROW SUPPRESSION CAUSED BY TWO YEARS OF ZIDOVUDINE ANTI-HIV THERAPY. C CHIN J AIDS STD 2013; 1 (19).",31,YR,,M,Y,,,20140710,N,MD,CN,CN,EFAVIRENZ,Anaemia;Bone marrow failure;Conjunctival pallor;Fatigue;Haemoglobin decreased;Mucosal discolouration;Neutropenia;Neutrophil count decreased;Palpitations;Red blood cell count decreased,102506772,HO,,,102506772,1,201004,20130308,,,102506772,1,HIV infection
10263507,102635072,2,F,20140603,20140807,20140626,20140813,EXP,,AR-GILEAD-2014-0106810,GILEAD,,36,YR,A,M,Y,64.5,KG,20140813,N,MD,AR,AR,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Intentional self-injury,102635072,OT,,,102635072,1,20130721,20140603,,,102635072,1,HIV infection
10268455,102684553,3,F,20140124,20140728,20140630,20140811,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-21050448,BRISTOL MYERS SQUIBB,,67,YR,E,M,Y,62,KG,20140811,N,OT,GB,GB,EFAVIRENZ TABS,Acute generalised exanthematous pustulosis;Off label use,102684553,HO,,,102684553,1,20140124,20140318,,,102684553,1,HIV infection
10270690,102706902,2,F,20140124,20140728,20140701,20140811,EXP,,GB-009507513-1407GBR000196,MERCK,,67,YR,,M,Y,,,20140811,N,OT,GB,GB,EFAVIRENZ,Acute generalised exanthematous pustulosis;Off label use,102706902,OT,,,102706902,1,20140124,20140318,,,102706902,1,HIV infection
10271631,102716313,3,F,20140621,20140723,20140701,20140728,EXP,,US-GILEAD-2014-0107470,GILEAD,,37,YR,A,F,Y,65.4,KG,20140908,N,MD,SZ,SZ,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Immune reconstitution inflammatory syndrome;Premature labour,102716313,DE,,,102716313,1,20140611,,,,102716313,1,HIV infection
10272117,102721171,1,I,,20140616,20140702,20140702,PER,,US-009507513-1406USA009400,MERCK,,18,YR,,F,Y,,,20140909,N,CN,US,US,SUSTIVA,No adverse event;Pregnancy,,,,,,,,,,,,,
10273158,102731581,1,I,,20140619,20140702,20140702,EXP,,US-MYLANLABS-2014S1015084,MYLAN,"BOSSE KR, RUSSELL EA, CHIKWAVA KR, RUTSTEIN RM, LOWENTHAL E. ACUTE RENAL INJURY IN A 14-YEAR-OLD WITH HIV/AIDS AND TUBERCULOSIS. PEDIATR-INFECT-DIS-J 2013; 32(9) E380-E382",14,YR,T,M,Y,,,20140702,N,MD,US,US,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis;Renal failure acute,102731581,HO,,,,,,,,,102731581,1,Acquired immunodeficiency syndrome
10273459,102734593,3,F,20140124,20140804,20140630,20140814,EXP,,AUR-APL-2014-06679,AUROBINDO,,67,YR,,M,N,62.0,KG,20140813,N,OT,GB,,EFAVIRENZ (EFAVIRENZ) UNKNOWN,Acute generalised exanthematous pustulosis;Off label use;Pyrexia;Rash maculo-papular;Swelling face,102734593,HO,102734593,FGN,102734593,1,20140124,20140711,,,102734593,1,Hepatitis C
10275995,102759951,1,I,20140422,,20140701,20140701,DIR,,,,,62,YR,,M,N,89.9,KG,20140617,N,PH,US,,EFAVIRENZ,Hypotension;Stevens-Johnson syndrome,102759951,RI,,,102759951,1,20140401,20140422,,,102759951,1,Infection
10281934,102819341,1,I,20140630,20140701,20140707,20140707,EXP,,UG-009507513-1407ZAF002351,MERCK,,41,YR,,M,Y,37,KG,20140707,N,OT,UG,UG,EFAVIRENZ,Anaemia;Bronchopneumonia;Dehydration;Leukopenia;Renal failure acute;Thrombocytopenia,102819341,HO,,,102819341,1,20140422,20140630,,,102819341,1,HIV infection
10282099,102820992,2,F,20140622,20140710,20140707,20140716,EXP,,UG-VIIV HEALTHCARE LIMITED-B1011074A,GLAXOSMITHKLINE,,41,YR,,M,Y,,,20140716,N,MD,UG,UG,EFAVIRENZ,Anaemia;Death;Dehydration;Leukopenia;Pneumonia;Renal failure acute;Thrombocytopenia,102820992,DE,,,102820992,1,20140422,20140617,,,102820992,1,HIV infection
10283933,102839332,2,F,2011,20140624,20140708,20140708,EXP,,US-ACTELION-A-NJ2014-99265,ACTELION,,42,YR,A,F,Y,,,20140708,N,OT,US,US,SUSTIVA,Abdominal distension;Cardiomegaly;Condition aggravated;Fatigue;Fluid retention;Liver function test abnormal;Oedema peripheral;Pulmonary arterial hypertension;Respiratory tract infection,102839332,HO,,,102839332,2,20101108,,,,102839332,1,Pulmonary arterial hypertension
10284739,102847391,1,I,20140604,20140703,20140708,20140708,EXP,,UG-GILEAD-2014-0107820,GILEAD,,51,YR,,M,Y,,,20140708,N,MD,UG,UG,EFAVIRENZ,Ascites;Diarrhoea;Pancreatitis,102847391,HO,,,102847391,1,20140507,20140617,,,102847391,1,HIV infection
10287058,102870581,1,I,,20140619,20140707,20140707,EXP,,2014AP003487,APOTEX,,14,YR,,M,N,,,20140702,N,,US,,EFAVIRENZ (EFAVIRENZ),Hepatosplenomegaly;Immune reconstitution inflammatory syndrome associated tuberculosis;Nephropathy toxic;Neuropathy peripheral;Paradoxical drug reaction;Renal failure acute;Tubulointerstitial nephritis,102870581,OT,102870581,HP,,,,,,,102870581,1,Acquired immunodeficiency syndrome
10287463,102874632,2,F,,20140709,20140709,20140710,EXP,,US-VIIV HEALTHCARE LIMITED-A1080252A,GLAXOSMITHKLINE,,62,YR,,M,Y,97.5,KG,20140710,N,MD,US,US,EFAVIRENZ,Lipoatrophy;Lipodystrophy acquired;Weight decreased,102874632,OT,,,102874632,1,20140407,20140404,,,102874632,1,Product used for unknown indication
10292094,102920941,1,I,,20140708,20140710,20140710,EXP,,MY-JNJFOC-20140706135,JANSSEN,"DING CH, TZAR MN, RAHMAN MM, MUTTAQILLAH NA, REDZUAN SR, PERIYASAMY P. PAECILOMYCES LILACINUS FUNGAEMIA IN AN AIDS PATIENT: THE IMPORTANCE OF MYCOLOGICAL DIAGNOSIS. PAK J MED SCI 2014;30(4):914-916.",25,YR,A,F,Y,,,20140710,N,OT,MY,MY,EFAVIRENZ,Disseminated intravascular coagulation;Drug ineffective;Multi-organ disorder,102920941,DE,,,,,,,,,102920941,1,Fungaemia
10292565,102925653,3,F,2013,20140708,20140710,20140715,EXP,,CH-GILEAD-2014-0106572,GILEAD,"WAGNER, N. 11 YEAR-OLD CHILD INFECTED WITH MULTI-DRUG-RESISTANT HIV. HOPITAL DES ENFANTS GENEVE. 2014;.:.",11,YR,,M,Y,56.5,KG,20140715,N,OT,CH,CH,EFAVIRENZ,Drug ineffective for unapproved indication;Off label use;Viraemia;Virologic failure,102925653,OT,,,102925653,1,201305,,,,102925653,1,HIV infection
10297433,102974334,4,F,20140313,20140729,20140711,20140801,EXP,,ZW-009507513-1403USA010627,MERCK,,37,YR,,M,Y,,,20140801,N,CN,US,ZW,EFAVIRENZ,Confusional state;Meningitis cryptococcal;Meningitis tuberculous,102974334,HO,,,102974334,1,20140305,20140328,,,102974334,1,HIV infection
10302492,103024922,2,F,20140703,20140710,20140714,20140715,EXP,,KE-009507513-1407KEN004689,MERCK,,46,YR,,M,Y,37.7,KG,20140716,N,CN,KE,KE,EFAVIRENZ,Abdominal abscess;Death;Diarrhoea;Jaundice;Malnutrition;Meningitis;Oesophageal candidiasis;Sepsis,103024922,HO,,,103024922,1,20140630,20140709,,,103024922,1,HIV infection
10304662,103046621,1,I,201401,20140703,20140715,20140715,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-21173422,BRISTOL MYERS SQUIBB,,54,YR,,F,Y,,,20140715,N,MD,FR,FR,SUSTIVA,Erythromelalgia,103046621,OT,,,103046621,1,201205,,,,,,
10305785,103057851,1,I,20140607,20140708,20140715,20140715,EXP,,KE-GILEAD-2014-0108131,GILEAD,,46,YR,,M,Y,37.3,KG,20140714,N,MD,KE,KE,EFAVIRENZ,Diarrhoea;Jaundice;Malnutrition;Meningitis;Mesenteric abscess;Oesophageal candidiasis;Sepsis,103057851,HO,,,103057851,1,20140630,20140709,,,103057851,1,HIV infection
10305812,103058121,1,I,20140122,20140711,20140715,20140715,EXP,,MW-GILEAD-2014-0108679,GILEAD,,16,YR,,F,Y,,,20140714,N,MD,MW,MW,EFAVIRENZ,Abdominal sepsis;Disseminated tuberculosis,103058121,OT,,,103058121,1,20140509,20140528,,,103058121,1,HIV infection
10305912,103059122,2,F,20140625,20140718,20140715,20140724,EXP,,MW-GILEAD-2014-0107993,GILEAD,,46,YR,,M,Y,,,20140724,N,MD,MW,MW,EFAVIRENZ,Disseminated tuberculosis,103059122,OT,,,103059122,1,20140613,20140613,,,103059122,1,HIV infection
10306286,103062861,1,I,20140224,20140714,20140715,20140715,EXP,,MW-GILEAD-2014-0108824,GILEAD,,40,YR,,F,Y,,,20140717,N,MD,MW,MW,EFAVIRENZ,Immune reconstitution inflammatory syndrome,103062861,OT,,,103062861,1,20140109,,,,103062861,1,HIV infection
10308252,103082522,2,F,20140131,20140711,20140716,20140725,EXP,,US-GILEAD-2014-0108664,GILEAD,,22,YR,,F,Y,,,20140725,N,OT,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion spontaneous;Complication of pregnancy,103082522,OT,,,103082522,1,20120625,20140128,,,103082522,1,HIV infection
10308846,103088461,1,I,,20140708,20140716,20140716,EXP,,UG-GILEAD-2014-0108511,GILEAD,"KIGGUNDU R, RHEIN J, MEYA DB, BOULWARE DR, BAHR NC. UNMASKING CRYPTOCOCCAL MENINGITIS IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN PREGNANCY INDUCED BY HIV ANTIRETROVIRAL THERAPY WITH POSTPARTUM PARADOXICAL EXACERBATION. MEDICAL MYCOLOGY CASE REPORTS. 2014;5 (1):16-19",32,YR,,F,Y,,,20140716,N,OT,UG,UG,EFAVIRENZ,Immune reconstitution inflammatory syndrome;Pregnancy,103088461,OT,,,,,,,,,103088461,1,HIV infection
10310757,103107571,1,I,,20140205,20140717,20140717,EXP,GB-MHRA-ADR 22330256,GB-TEVA-494934GER,TEVA,,39,YR,,M,Y,,,20140717,N,MD,GB,GB,SUSTIVA,Depression;Drug interaction;Drug level decreased,103107571,OT,,,103107571,2,,201311,,,103107571,1,Product used for unknown indication
10311481,103114811,1,I,,20140708,20140717,20140717,EXP,,FR-JNJFOC-20140705079,JANSSEN,"LEPORRIER J, ETIENNE M, CHAPUZET C, PEYTAVIN G, BORD S, LEBAS FB, ET AL. ASSOCIATION OF DOLUTEGRAVIR AND RILPIVIRINE, ENHANCED BY FOSCARNET INDUCTION, IN EFFECTIVE SALVAGE ANTIRETROVIRAL THERAPY. JOURNAL OF CLINICAL VIROLOGY 2014;60(4):428-430.",23,YR,A,M,Y,,,20140717,N,OT,FR,FR,EFAVIRENZ,Decreased immune responsiveness;No therapeutic response;Treatment noncompliance,103114811,OT,,,,,,,,,103114811,1,HIV infection
10311591,103115911,1,I,,20140708,20140717,20140717,EXP,,UG-VIIV HEALTHCARE LIMITED-B1014138A,GLAXOSMITHKLINE,"  KIGGUNDU R, RHEIN J, MEYA DB, BOULWARE DR, BAHR NC. UNMASKINGCRYPTOCOCCALMENINGITISIMMUNERECONSTITUTION INFLAMMATORYSYNDROMEINPREGNANCYINDUCEDBYHIVANTIRETROVIRAL THERAPYWITHPOSTPARTUMPARADOXICALEXACERBATION. MEDICALMYCOLOGYCASEREPORTS 2014; 5: 16-19",32,YR,,F,Y,,,20140717,N,MD,UG,UG,EFAVIRENZ,Asthenia;Disorientation;Dyspnoea;Exposure during pregnancy;Headache;Hypoaesthesia;Immune reconstitution inflammatory syndrome;Live birth;Meningitis cryptococcal;Mental status changes;Musculoskeletal stiffness;Nuchal rigidity;Pyrexia;Respiratory failure;Rhonchi;Vomiting,103115911,DE,,,,,,,,,103115911,1,HIV infection
10311592,103115921,1,I,,20140708,20140717,20140717,EXP,,UG-VIIV HEALTHCARE LIMITED-B1014138B,GLAXOSMITHKLINE,,,,N,F,Y,,,20140717,N,MD,UG,UG,EFAVIRENZ,Foetal exposure during pregnancy;Respiratory distress,103115921,HO,,,,,,,,,103115921,1,HIV infection
10312565,103125652,2,F,20090522,20140715,20140718,20140718,EXP,,JP-009507513-1008USA00405,MERCK,,64,YR,,M,Y,,,20140728,N,CN,US,JP,EFAVIRENZ,Diabetes mellitus;Diffuse large B-cell lymphoma;Mycobacterium avium complex infection;Pancytopenia;Tuberculosis,103125652,LT,,,103125652,1,20090217,20090624,,,103125652,2,HIV infection
10314343,103143431,1,I,,20140710,20140718,20140718,EXP,,FR-VIIV HEALTHCARE LIMITED-B1015516A,GLAXOSMITHKLINE,,23,YR,,M,Y,,,20140718,N,MD,FR,FR,EFAVIRENZ,Drug ineffective;Drug resistance;Immune system disorder;Nephropathy toxic;Opportunistic infection;Pneumonia;Pyrexia;Treatment noncompliance,103143431,HO,,,,,,,,,103143431,1,HIV infection
10331818,103318182,2,F,20140505,20140819,20140722,20140820,EXP,,VN-GILEAD-2014-0108954,GILEAD,,40,YR,A,M,Y,,,20140820,N,MD,VN,VN,EFAVIRENZ,Central nervous system infection,103318182,OT,,,103318182,1,20131226,,,,103318182,1,HIV infection
10331894,103318941,1,I,20140710,20140714,20140722,20140722,EXP,,IN-BRISTOL-MYERS SQUIBB COMPANY-21212568,BRISTOL MYERS SQUIBB,,29,YR,,F,Y,43,KG,20140718,N,CN,US,IN,EFAVIRENZ,Leukopenia;Neutropenia,103318941,OT,,,103318941,1,20120217,20140710,,,103318941,1,HIV infection
10331937,103319372,2,F,201202,20140715,20140722,20140722,EXP,,FR-ABBVIE-13P-056-1086790-00,ABBVIE,,51,YR,,M,Y,,,20140722,N,MD,FR,FR,SUSTIVA,Axonal neuropathy;Hypokinesia;Muscular weakness;Pain;Spinal muscular atrophy,103319372,DS,,,103319372,1,2005,20111102,,,103319372,1,HIV infection
10332141,103321412,2,F,20140703,20140710,20140722,20140724,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-21212535,BRISTOL MYERS SQUIBB,,46,YR,,M,Y,37.7,KG,20140724,N,CN,GB,KE,EFAVIRENZ,Death;Diarrhoea;Immune reconstitution inflammatory syndrome;Jaundice;Malnutrition;Meningitis;Oesophageal candidiasis,103321412,DE,,,103321412,1,20140630,20140709,,,103321412,1,Antiretroviral therapy
10332211,103322113,3,F,20140313,20140729,20140722,20140806,EXP,,ZW-BRISTOL-MYERS SQUIBB COMPANY-20567020,BRISTOL MYERS SQUIBB,,37,YR,,M,Y,,,20140806,N,CN,US,ZW,EFAVIRENZ TABS,Extrapulmonary tuberculosis;Meningitis cryptococcal,103322113,HO,,,103322113,1,20140305,20140306,,,103322113,1,HIV infection
10339319,103393191,1,I,20140324,,20140723,20140723,DIR,,,,,51,YR,,M,N,92.5,KG,20140721,N,PH,US,,EFAVIRENZ,Cholestatic liver injury;Drug-induced liver injury;Hepatocellular injury,103393191,HO,103393191,HP,103393191,1,19991202,20140613,,,103393191,1,Hepatitis acute
10339973,103399731,1,I,,20140711,20140722,20140722,EXP,,KAD201407-000783,KADMON,,,,,M,N,,,20140721,N,OT,JP,,EFAVIRENZ (EFAVIRENZ),Anaemia;Basedow's disease;Drug level increased;Haemophilic arthropathy;Headache;Hepatic fibrosis;Hypothyroidism;Therapy responder,103399731,OT,103399731,LIT,,,,,,,103399731,2,Hepatitis C
10344314,103443142,2,F,20120320,20140716,20140728,20140728,PER,,US-BIOGENIDEC-2012BI010006,BIOGEN,,44,YR,A,M,Y,76,KG,20140728,N,MD,US,US,EFAVIRENZ,Device dislocation;Post procedural haemorrhage,103443142,HO,,,103443142,1,20120106,20120315,,,103443142,1,Factor VIII deficiency
10345808,103458082,2,F,20140304,20140908,20140728,20140910,EXP,,US-GILEAD-2014-0110138,GILEAD,,0,YR,N,M,Y,,,20140910,N,OT,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Polydactyly,103458082,CA,,,103458082,1,20131209,20140710,,,103458082,1,HIV infection
10354326,103543261,1,I,,20140723,20140731,20140731,EXP,,TR-ASTELLAS-2014US009138,ASTELLAS,,52,YR,,M,Y,,,20140730,N,CN,US,TR,EFAVIRENZ,Drug ineffective,103543261,DE,,,,,,,,,103543261,1,Zygomycosis
10354387,103543871,1,I,,20140728,20140731,20140731,EXP,,GB-MERCK-1407GBR014141,MERCK,,46,YR,,M,Y,,,20140731,N,CN,GB,GB,EFAVIRENZ,Death,103543871,DE,,,,,,,,,,,
10355569,103555692,2,F,20140124,20140728,20140731,20140731,EXP,,GB-GILEAD-2014-0105746,GILEAD,,67,YR,,M,Y,62,KG,20140731,N,CN,GB,GB,EFAVIRENZ,Acute generalised exanthematous pustulosis;Off label use,103555692,OT,,,103555692,1,20140124,20140318,,,103555692,1,HIV infection
10357865,103578651,1,I,,20140718,20140801,20140801,EXP,,UG-BRISTOL-MYERS SQUIBB COMPANY-21230743,BRISTOL MYERS SQUIBB,,32,YR,,M,Y,,,20140801,N,CN,GB,UG,EFAVIRENZ,Death;Malaria,103578651,DE,,,103578651,1,20140610,20140616,,,,,
10359486,103594862,2,F,20140124,20140729,20140804,20140804,EXP,,GB-ROCHE-1421172,ROCHE,,67,YR,,M,Y,62,KG,20140804,N,OT,GB,GB,EFAVIRENZ,Acute generalised exanthematous pustulosis;Off label use,103594862,HO,,,103594862,1,20140124,20140704,,,103594862,1,Hepatitis C
10360655,103606551,1,I,,20140726,20140804,20140804,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-21250568,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20140804,N,MD,DE,DE,SUSTIVA,Cerebrovascular accident,103606551,OT,,,,,,,,,103606551,1,HIV infection
10360676,103606761,1,I,20140713,20140722,20140804,20140804,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-21253224,BRISTOL MYERS SQUIBB,,37,YR,,M,Y,,,20140805,N,CN,GB,MW,EFAVIRENZ,Anaemia;Sepsis,103606761,HO,,,103606761,1,20140710,,,,103606761,1,HIV infection
10360829,103608292,2,F,,20140923,20140804,20140924,EXP,,KE-VIIV HEALTHCARE LIMITED-B1020311A,GLAXOSMITHKLINE,,56,YR,,M,Y,70,KG,20140924,N,MD,KE,KE,EFAVIRENZ,Pruritus;Scratch,103608292,OT,,,,,,,,,103608292,1,Product used for unknown indication
10363160,103631602,2,F,20130902,20140729,20140805,20140805,EXP,,UG-009507513-1309UGA007734,MERCK,,23,YR,,F,Y,,,20140805,N,MD,UG,UG,EFAVIRENZ,Lymph node tuberculosis;Neuropathy peripheral;Pulmonary tuberculosis,103631602,LT,,,103631602,1,20130815,,,,103631602,1,HIV infection
10363299,103632992,2,F,20090515,20140909,20140805,20140918,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-21250303,BRISTOL MYERS SQUIBB,,37,YR,,F,Y,,,20140918,N,CN,FR,FR,SUSTIVA,Hepatitis fulminant,103632992,LT,,,103632992,1,20090503,20090516,,,103632992,1,HIV infection
10363308,103633081,1,I,,20140728,20140805,20140805,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-21256490,BRISTOL MYERS SQUIBB,,46,YR,,M,Y,,,20140805,N,CN,GB,GB,SUSTIVA,Death,103633081,DE,,,,,,,,,,,
10363476,103634762,2,F,20131112,20140922,20140805,20140922,EXP,,CN-VIIV HEALTHCARE LIMITED-B1020155A,GLAXOSMITHKLINE,,76,YR,,M,Y,51,KG,20140922,N,OT,CN,CN,EFAVIRENZ,Renal impairment,103634762,OT,,,103634762,1,20131104,20131126,,,103634762,1,HIV infection
10364338,103643381,1,I,,20140729,20140806,20140806,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-21253414,BRISTOL MYERS SQUIBB,,25,YR,,M,Y,,,20140806,N,CN,US,US,SUSTIVA,Death,103643381,DE,,,,,,,,,,,
10366013,103660133,3,F,20140516,20140814,20140806,20140820,EXP,,MW-VIIV HEALTHCARE LIMITED-A1084018A,GLAXOSMITHKLINE,,0,DY,,M,Y,1.7,KG,20140820,N,OT,MW,MW,EFAVIRENZ,Accessory auricle;Foetal exposure during pregnancy;Premature baby,103660133,CA,,,103660133,1,20110608,20140410,,,103660133,1,HIV infection
10366053,103660531,1,I,,20140729,20140806,20140806,EXP,,ZA-VIIV HEALTHCARE LIMITED-B1020951A,GLAXOSMITHKLINE,"MOODLEY A, BHOLA S, OMAR F, MOGAMBERY J. ANTIRETROVIRAL THERAPY-INDUCED LEBER^S HEREDITARY OPTIC NEUROPATHY. SOUTH AFRICAN JOURNAL OF HIV MEDICINE. 2014; 15(2).",31,YR,,M,Y,,,20140806,N,MD,ZA,ZA,EFAVIRENZ,Blindness;Optic atrophy;Optic neuropathy,103660531,OT,,,,,,,,,103660531,1,HIV infection
10366054,103660541,1,I,,20140729,20140806,20140806,EXP,,ZA-VIIV HEALTHCARE LIMITED-B1020960A,GLAXOSMITHKLINE,"MOODLEY A, BHOLA S, OMAR F, MOGAMBERY J. ANTIRETROVIRAL THERAPY-INDUCED LEBER^S HEREDITARY OPTIC NEUROPATHY. SOUTH AFRICAN JOURNAL OF HIV MEDICINE. 2014; 15(2).",33,YR,,M,Y,,,20140806,N,MD,ZA,ZA,EFAVIRENZ,Blindness;Optic atrophy;Optic neuropathy;Visual field defect,103660541,OT,,,,,,,,,103660541,1,HIV infection
10367170,103671701,1,I,,20140730,20140807,20140807,EXP,,KR-BRISTOL-MYERS SQUIBB COMPANY-21276209,BRISTOL MYERS SQUIBB,,,,,,Y,,,20140807,N,CN,US,KR,EFAVIRENZ,Death,103671701,DE,,,,,,,,,,,
10368206,103682061,1,I,,20140730,20140807,20140807,EXP,,IN-GILEAD-2014-0110777,GILEAD,"PATOLE S, BURZA S, VARGHESE G.M. MULTIPLE RELAPSES OF VISCERAL LEISHMANIASIS IN A PATIENT WITH HIV IN INDIA: A TREATMENT CHALLENGE. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2014;25:204-06",43,YR,A,M,Y,,,20140807,N,OT,IN,IN,EFAVIRENZ,CD4 lymphocytes decreased;Drug ineffective,103682061,HO,,,,,,,,,103682061,1,Visceral leishmaniasis
10369833,103698331,1,I,20140318,20140805,20140808,20140808,EXP,,GB-009507513-1408GBR002193,MERCK,,67,YR,,M,Y,62,KG,20140808,N,OT,GB,GB,EFAVIRENZ,Anal abscess;Periorbital oedema;Rash,103698331,HO,,,103698331,1,20140122,20140711,,,103698331,1,Hepatitis C
10371770,103717701,1,I,,20140801,20140808,20140808,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-21268255,BRISTOL MYERS SQUIBB,,46,YR,,M,Y,,,20140808,N,CN,GB,GB,EFAVIRENZ,Death,103717701,DE,,,,,,,,,,,
10371796,103717962,2,F,20140617,20140731,20140808,20140808,EXP,,KE-BRISTOL-MYERS SQUIBB COMPANY-21228531,BRISTOL MYERS SQUIBB,,47,YR,,M,Y,,,20140808,N,CN,KE,KE,EFAVIRENZ,Confusional state;Meningitis tuberculous,103717962,DE,,,103717962,1,20140528,20140719,,,103717962,1,Antiretroviral therapy
10374903,103749031,1,I,,20140730,20140811,20140811,EXP,,IN-ASTELLAS-2014US009862,ASTELLAS,,43,YR,,M,Y,,,20140808,N,CN,GB,IN,EFAVIRENZ,CD4 lymphocytes decreased;Drug ineffective,103749031,HO,,,,,,,,,103749031,1,Visceral leishmaniasis
10375974,103759741,1,I,,20140801,20140811,20140811,EXP,,GB-GILEAD-2014-0110975,GILEAD,,30,YR,A,F,Y,,,20140811,N,OT,GB,GB,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abortion spontaneous,103759741,OT,,,103759741,1,20140405,,,,103759741,1,HIV infection
10376054,103760541,1,I,,20140807,20140811,20140811,EXP,,US-BMSGILMSD-2014-0111468,GILEAD,,30,YR,A,M,Y,,,20140811,N,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Drug ineffective;Nausea,103760541,OT,,,,,,,,,103760541,1,HIV infection
10376122,103761224,4,F,,20140826,20140811,20140901,EXP,,MW-BRISTOL-MYERS SQUIBB COMPANY-21278197,BRISTOL MYERS SQUIBB,,,,,M,Y,1.7,KG,20150112,N,CN,US,MW,EFAVIRENZ,Accessory auricle;Foetal exposure during pregnancy;Premature baby,103761224,OT,,,103761224,1,20110608,20140410,,,103761224,1,Antiretroviral therapy
10377323,103773231,1,I,,20140801,20140812,20140812,EXP,,GB-009507513-1408GBR006042,MERCK,,46,YR,,M,Y,,,20140812,N,CN,US,GB,EFAVIRENZ,Death,103773231,DE,,,,,,,,,,,
10379836,103798362,2,F,201010,20140903,20140812,20140909,EXP,,US-GILEAD-2014-0111462,GILEAD,"LINDSEY S, WEISS J, LEE E, ROMANELLI P. TREATMENT OF SEVERE PSORIASIS AND PSORIATIC ARTHRITIS WITH ADALIMUMAB IN AN HIV-POSITIVE PATIENT.. JOURNAL OF DRUGS IN DERMATOLOGY. 2014;13:869-871",49,YR,A,M,Y,,,20140909,N,MD,US,US,EFAVIRENZ,Drug ineffective;Drug resistance;Psoriasis;Psoriatic arthropathy,103798362,OT,,,103798362,1,201005,201010,,,103798362,1,HIV infection
10381275,103812751,1,I,20131124,20140806,20140813,20140813,EXP,GB-MHRA-EYC 00113380,GB-GILEAD-2014-0111362,GILEAD,,52,YR,A,M,Y,67,KG,20140813,N,MD,GB,GB,EFAVIRENZ,Coagulopathy,103812751,OT,,,103812751,1,20130101,20140624,,,103812751,1,HIV antibody positive
10382748,103827482,2,F,2014,20140820,20140813,20140825,EXP,,US-GILEAD-2014-0111709,GILEAD,,51,YR,A,M,Y,,,20140825,N,MD,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Blood cholesterol increased;Myocardial infarction,103827482,OT,,,103827482,1,,2014,,,103827482,1,HIV infection
10383993,103839931,1,I,,20140731,20140814,20140814,EXP,,KR-MYLAN-2014M1001254,MYLAN,"KIM H-S, SHIN H-S. ALOPECIA AREATA ASSOCIATED WITH ABACAVIR THERAPY. INFECT-CHEMOTHERAP 2014; 46(2) 103-105",,,,,Y,,,20140814,N,OT,KR,KR,EFAVIRENZ,Abdominal distension;Alopecia areata;Diarrhoea,103839931,OT,,,,,,,,,103839931,1,HIV infection
10391504,103915041,1,I,20140717,20140815,20140818,20140818,EXP,,UG-GILEAD-2014-0112277,GILEAD,,25,YR,A,F,Y,,,20140910,N,MD,UG,UG,EFAVIRENZ,Cachexia;Dehydration;Diarrhoea;Oral candidiasis;Pulmonary tuberculosis,103915041,OT,,,103915041,1,20140630,20140729,,,103915041,1,HIV infection
10392976,103929761,1,I,,20140804,20140815,20140815,EXP,,2014AU01132,CIPLA,,,,,,N,,,20140814,N,,AU,,EFAVIRENZ (EFAVIRENZ),Central nervous system lymphoma,103929761,DE,103929761,HP,,,,,,,103929761,1,HIV infection
10392993,103929931,1,I,,20140804,20140815,20140815,EXP,,2014AU01133,CIPLA,,,,,,N,,,20140814,N,,AU,,EFAVIRENZ,Septic shock,103929931,DE,103929931,FGN,,,,,,,103929931,1,HIV infection
10393009,103930091,1,I,,20140804,20140815,20140815,EXP,,2014AU01135,CIPLA,,,,,,N,,,20140814,N,,AU,,EFAVIRENZ,Completed suicide;Poisoning deliberate,103930091,DE,103930091,HP,,,,,,,103930091,1,HIV infection
10393062,103930621,1,I,,20140804,20140815,20140815,EXP,,2014AU01130,CIPLA,,,,,,N,,,20140814,N,,AU,,EFAVIRENZ,Non-Hodgkin's lymphoma,103930621,DE,103930621,LIT,,,,,,,103930621,1,HIV infection
10393082,103930821,1,I,,20140804,20140815,20140815,EXP,,2014AU01134,CIPLA,,,,,,N,,,20140814,N,,AU,,EFAVIRENZ,Acinetobacter infection;Pneumonia,103930821,DE,103930821,FGN,,,,,,,103930821,1,HIV infection
10393119,103931191,1,I,,20140804,20140815,20140815,EXP,,2014FR01118,CIPLA,,,,,,N,,,20140814,N,,FR,,EFAVIRENZ,Gout,103931191,OT,103931191,FGN,,,,,,,103931191,1,HIV infection
10393648,103936481,1,I,20140730,20140813,20140819,20140819,EXP,,US-GILEAD-2014-0112056,GILEAD,,56,YR,A,M,Y,,,20140822,N,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Pruritus;Rash,,,,,103936481,1,20140730,,,,103936481,1,HIV infection
10393670,103936701,1,I,,20140804,20140815,20140815,EXP,,2014FR01120,CIPLA,,,,,,N,,,20140814,N,OT,FR,,EFAVIRENZ,Osteoporosis,103936701,OT,103936701,HP,,,,,,,103936701,1,HIV infection
10393790,103937901,1,I,,20140804,20140815,20140815,EXP,,2014DK01021,CIPLA,,,,,,N,,,20140814,N,,DK,,TENOFOVIR/LAMIVUDINE/EFAVIRENZ TABLET,Drug resistance,103937901,OT,103937901,HP,,,,,,,,,
10393805,103938051,1,I,,20140804,20140815,20140815,EXP,,2014AU01129,CIPLA,,,,,F,N,,,20140814,N,,AU,,EFAVIRENZ (EFAVIRENZ),Abortion spontaneous;Maternal exposure during pregnancy,103938051,OT,103938051,HP,,,,,,,103938051,1,HIV infection
10396729,103967291,1,I,,20140811,20140820,20140820,EXP,,FR-VIIV HEALTHCARE LIMITED-B1022655A,GLAXOSMITHKLINE,,,,,F,Y,,,20140820,N,MD,FR,FR,SUSTIVA,Macrocytosis,103967291,OT,,,103967291,1,20001017,20080416,,,103967291,1,HIV infection
10398025,103980251,1,I,,20140804,20140818,20140818,EXP,,2014AU01127,CIPLA,,,,,F,N,,,20140814,N,,AU,,EFAVIRENZ,Abortion induced;Exposure during pregnancy,103980251,OT,103980251,FGN,,,,,,,103980251,1,HIV infection
10399937,103999372,2,F,20140718,20140821,20140821,20140822,EXP,,UG-VIIV HEALTHCARE LIMITED-B1025498A,GLAXOSMITHKLINE,,43,YR,,F,Y,,,20140822,N,MD,UG,UG,EFAVIRENZ,Cardiac failure congestive,103999372,DE,,,103999372,1,20140612,20140808,,,103999372,1,HIV infection
10400731,104007311,1,I,,20140813,20140821,20140821,EXP,,ES-GILEAD-2014-0112123,GILEAD,"BARRIOS A, NEGREDO E, DOMINGO P, ESTRADA V, LABARGA P, ASENSI V, MORALES D, SANTOS J, CLOTET B AND SORIANO V.. SIMPLIFICATION THERAPY WITH ONCE-DAILY DIDANOSINE,TENOFOVIR AND EFAVIRENZ IN HIV-1-INFECTED ADULTS WITH VIRAL SUPPRESSION RECEIVING A MORE COMPLEX ANTIRETROVIRAL REGIMEN: FINAL RESULTS OF THE EFADITE TRIAL. ANTIVIRAL THERAPY. 2005;10 (7):825-32",,,A,,Y,,,20140821,N,OT,ES,ES,EFAVIRENZ,Genotype drug resistance test positive;Virologic failure,104007311,OT,,,,,,,,,104007311,1,HIV infection
10400904,104009041,1,I,,20140813,20140821,20140821,EXP,,ES-GILEAD-2014-0112122,GILEAD,"BARRIOS A, NEGREDO E, DOMINGO P, ESTRADA V, LABARGA P, ASENSI V, MORALES D, SANTOS J, CLOTET B AND SORIANO V.. SIMPLIFICATION THERAPY WITH ONCE-DAILY DIDANOSINE TENOFOVIR AND EFAVIRENZ IN HIV-1-INFECTED ADULTS WITH VIRAL SUPPRESSION RECEIVING A MORE COMPLEX ANTIRETROVIRAL REGIMEN: FINAL RESULTS OF THE EFADITE TRIAL. ANTIVIRAL THERAPY. 2005;10 (7):825-32",,,A,,Y,,,20140821,N,OT,ES,ES,EFAVIRENZ,Genotype drug resistance test positive;Virologic failure,104009041,OT,,,,,,,,,104009041,1,HIV infection
10400909,104009091,1,I,,20140813,20140821,20140821,EXP,,ES-GILEAD-2014-0112291,GILEAD,"BARRIOS A, NEGREDO E, DOMINGO P, ESTRADA V, LABARGA P, ASENSI V, MORALES D, SANTOS J, CLOTET B AND SORIANO V.. SIMPLIFICATION THERAPY WITH ONCE-DAILY DIDANOSINE TENOFOVIR AND EFAVIRENZ IN HIV-1-INFECTED ADULTS WITH VIRAL SUPPRESSION RECEIVING A MORE COMPLEX ANTIRETROVIRAL REGIMEN: FINAL RESULTS OF THE EFADITE TRIAL. ANTIVIRAL THERAPY. 2005;10 (7):825-32",,,A,,Y,,,20140821,N,OT,ES,ES,EFAVIRENZ,Genotype drug resistance test positive;Virologic failure,104009091,OT,,,,,,,,,104009091,1,HIV infection
10400916,104009161,1,I,,20140813,20140821,20140821,EXP,,ES-GILEAD-2014-0112292,GILEAD,"BARRIOS A, NEGREDO E, DOMINGO P, ESTRADA V, LABARGA P, ASENSI V, MORALES D, SANTOS J, CLOTET B AND SORIANO V.. SIMPLIFICATION THERAPY WITH ONCE-DAILY DIDANOSINE TENOFOVIR AND EFAVIRENZ IN HIV-1-INFECTED ADULTS WITH VIRAL SUPPRESSION RECEIVING A MORE COMPLEX ANTIRETROVIRAL REGIMEN: FINAL RESULTS OF THE EFADITE TRIAL. ANTIVIRAL THERAPY. 2005;10 (7):825-32",,,A,,Y,,,20140821,N,OT,ES,ES,EFAVIRENZ,Genotype drug resistance test positive;Virologic failure,104009161,OT,,,,,,,,,104009161,1,HIV infection
10400925,104009251,1,I,,20140813,20140821,20140821,EXP,,ES-GILEAD-2014-0112293,GILEAD,"BARRIOS A, NEGREDO E, DOMINGO P, ESTRADA V, LABARGA P, ASENSI V, MORALES D, SANTOS J, CLOTET B AND SORIANO V.. SIMPLIFICATION THERAPY WITH ONCE-DAILY DIDANOSINE TENOFOVIR AND EFAVIRENZ IN HIV-1-INFECTED ADULTS WITH VIRAL SUPPRESSION RECEIVING A MORE COMPLEX ANTIRETROVIRAL REGIMEN: FINAL RESULTS OF THE EFADITE TRIAL. ANTIVIRAL THERAPY. 2005;10 (7):825-32",,,A,,Y,,,20140821,N,OT,ES,ES,EFAVIRENZ,Genotype drug resistance test positive;Virologic failure,104009251,OT,,,,,,,,,104009251,1,HIV infection
10400927,104009271,1,I,,20140813,20140821,20140821,EXP,,ES-GILEAD-2014-0112294,GILEAD,"BARRIOS A, NEGREDO E, DOMINGO P, ESTRADA V, LABARGA P, ASENSI V, MORALES D, SANTOS J, CLOTET B AND SORIANO V.. SIMPLIFICATION THERAPY WITH ONCE-DAILY DIDANOSINE TENOFOVIR AND EFAVIRENZ IN HIV-1-INFECTED ADULTS WITH VIRAL SUPPRESSION RECEIVING A MORE COMPLEX ANTIRETROVIRAL REGIMEN: FINAL RESULTS OF THE EFADITE TRIAL. ANTIVIRAL THERAPY. 2005;10 (7):825-32",,,A,,Y,,,20140821,N,OT,ES,ES,EFAVIRENZ,Genotype drug resistance test positive;Virologic failure,104009271,OT,,,,,,,,,104009271,1,HIV infection
10400929,104009291,1,I,,20140813,20140821,20140821,EXP,,ES-GILEAD-2014-0112295,GILEAD,"BARRIOS A, NEGREDO E, DOMINGO P, ESTRADA V, LABARGA P, ASENSI V, MORALES D, SANTOS J, CLOTET B AND SORIANO V.. SIMPLIFICATION THERAPY WITH ONCE-DAILY DIDANOSINE TENOFOVIR AND EFAVIRENZ IN HIV-1-INFECTED ADULTS WITH VIRAL SUPPRESSION RECEIVING A MORE COMPLEX ANTIRETROVIRAL REGIMEN: FINAL RESULTS OF THE EFADITE TRIAL. ANTIVIRAL THERAPY. 2005;10 (7):825-32",,,A,,Y,,,20140821,N,OT,ES,ES,EFAVIRENZ,Genotype drug resistance test positive;Virologic failure,104009291,OT,,,,,,,,,104009291,1,HIV infection
10400940,104009401,1,I,,20140813,20140821,20140821,EXP,,ES-GILEAD-2014-0112434,GILEAD,"BARRIOS A, NEGREDO E, DOMINGO P, ESTRADA V, LABARGA P, ASENSI V, MORALES D, SANTOS J, CLOTET B AND SORIANO V.. SIMPLIFICATION THERAPY WITH ONCE-DAILY DIDANOSINE,TENOFOVIR AND EFAVIRENZ IN HIV-1-INFECTED ADULTS WITH VIRAL SUPPRESSION RECEIVING A MORE COMPLEX ANTIRETROVIRAL REGIMEN: FINAL RESULTS OF THE EFADITE TRIAL. ANTIVIRAL THERAPY. 2005;10 (7):825-32",,,A,,Y,,,20140821,N,OT,ES,ES,EFAVIRENZ,Genotype drug resistance test positive;Virologic failure,104009401,OT,,,,,,,,,104009401,1,HIV infection
10400942,104009421,1,I,,20140813,20140821,20140821,EXP,,ES-GILEAD-2014-0112435,GILEAD,"BARRIOS A, NEGREDO E, DOMINGO P, ESTRADA V, LABARGA P, ASENSI V, MORALES D, SANTOS J, CLOTET B AND SORIANO V.. SIMPLIFICATION THERAPY WITH ONCE-DAILY DIDANOSINE,TENOFOVIR AND EFAVIRENZ IN HIV-1-INFECTED ADULTS WITH VIRAL SUPPRESSION RECEIVING A MORE COMPLEX ANTIRETROVIRAL REGIMEN: FINAL RESULTS OF THE EFADITE TRIAL. ANTIVIRAL THERAPY. 2005;10 (7):825-32",,,A,,Y,,,20140821,N,OT,ES,ES,EFAVIRENZ,Genotype drug resistance test positive;Virologic failure,104009421,OT,,,,,,,,,104009421,1,HIV infection
10400946,104009461,1,I,,20140813,20140821,20140821,EXP,,ES-GILEAD-2014-0112436,GILEAD,"BARRIOS A, NEGREDO E, DOMINGO P, ESTRADA V, LABARGA P, ASENSI V, MORALES D, SANTOS J, CLOTET B AND SORIANO V.. SIMPLIFICATION THERAPY WITH ONCE-DAILY DIDANOSINE,TENOFOVIR AND EFAVIRENZ IN HIV-1-INFECTED ADULTS WITH VIRAL SUPPRESSION RECEIVING A MORE COMPLEX ANTIRETROVIRAL REGIMEN: FINAL RESULTS OF THE EFADITE TRIAL. ANTIVIRAL THERAPY. 2005;10 (7):825-32",,,A,,Y,,,20140821,N,OT,ES,ES,EFAVIRENZ,Genotype drug resistance test positive;Virologic failure,104009461,OT,,,,,,,,,104009461,1,HIV infection
10410494,104104941,1,I,,20140818,20140826,20140826,EXP,,UZ-VIIV HEALTHCARE LIMITED-B1027202A,GLAXOSMITHKLINE,,,,,M,Y,,,20140826,N,CN,UZ,UZ,EFAVIRENZ,Diarrhoea;Poisoning,104104941,HO,,,,,,,,,104104941,1,HIV infection
10411030,104110303,3,F,20140703,20140912,20140826,20140918,EXP,,HT-GILEAD-2014-0108018,GILEAD,,33,YR,A,M,Y,,,20140918,N,MD,HT,HT,EFAVIRENZ,Anaemia;Renal failure acute;Respiratory tract infection;Sepsis syndrome,104110303,LT,,,104110303,1,20130905,20140702,,,104110303,1,HIV infection
10411318,104113181,1,I,,20140822,20140826,20140826,EXP,,US-BMSGILMSD-2014-0113134,GILEAD,,41,YR,A,F,Y,,,20140826,N,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Loss of consciousness;Unevaluable event,104113181,HO,,,,,,,,,104113181,1,HIV infection
10412510,104125101,1,I,,20140819,20140827,20140827,EXP,,CM-SA-2014SA113509,AVENTIS,"WANDA F, NKEMENANG P, EHOUNOU G, TCHATON M, COMTE E, TRELLU LT, ET AL. CLINICAL FEATURES AND MANAGEMENT OF A SEVERE PARADOXICAL REACTION ASSOCIATED WITH COMBINED TREATMENT OF BURULI ULCER AND HIV CO-INFECTION. BMC INFECTIOUS DISEASE. 2014;14:423. AVAILABLE FROM: HTTP://WWW.BIOMEDCENTRAL.COM/1471-2334/14/423",30,YR,A,M,Y,65,KG,20140827,N,OT,CM,CM,EFAVIRENZ,Granuloma;Inflammation;Necrosis;Oedema;Paradoxical drug reaction;Skin lesion;Skin ulcer,104125101,HO,,,104125101,1,201301,20130303,,,104125101,1,Mycobacterium ulcerans infection
10412511,104125111,1,I,,20140819,20140827,20140827,EXP,,CM-SA-2014SA113509,AVENTIS,"WANDA F, NKEMENANG P, EHOUNOU G, TCHATON M, COMTE E, TRELLU LT, ET AL. CLINICAL FEATURES AND MANAGEMENT OF A SEVERE PARADOXICAL REACTION ASSOCIATED WITH COMBINED TREATMENT OF BURULI ULCER AND HIV CO-INFECTION. BMC INFECTIOUS DISEASE. 2014;14:423. AVAILABLE FROM: HTTP://WWW.BIOMEDCENTRAL.COM/1471-2334/14/423",30,YR,A,M,Y,65,KG,20140827,N,OT,CM,CM,EFAVIRENZ,Granuloma;Inflammation;Necrosis;Oedema;Paradoxical drug reaction;Skin lesion;Skin ulcer,104125111,HO,,,104125111,1,201301,20130303,,,104125111,1,Mycobacterium ulcerans infection
10412840,104128401,1,I,,20140821,20140827,20140827,EXP,,CM-PFIZER INC-2014234194,PFIZER,WANDA F.. CLINICAL FEATURES AND MANAGEMENT OF A SEVERE PARADOXICAL REACTION ASSOCIATED WITH COMBINED TREATMENT OF BURULI ULCER AND HIV CO-INFECTION. BMC INFECTIOUS DISEASES. 2014;14 (1),30,YR,,M,Y,65,KG,20140827,N,OT,CM,CM,EFAVIRENZ,Paradoxical drug reaction,104128401,HO,,,104128401,1,20130119,20130303,,,104128401,1,Antibiotic therapy
10414372,104143721,1,I,,20140818,20140828,20140828,EXP,,US-CIPLA LTD.-2014ZM01150,CIPLA,"LIU K, FARAHANI M, MASHAMBA T, MAWELA M, JOSEPH J, VAN SCHAIK N, HONEY E, GILL M, JASSAT W, STRINGER E, CHINTU N, MARLINK R. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;00:1-10",,,I,,Y,,,20140828,N,OT,US,ZM,EFAVIRENZ,Exposure during pregnancy;Preauricular cyst,104143721,CA,,,,,,,,,,,
10414418,104144181,1,I,,20140818,20140828,20140828,EXP,,US-CIPLA LTD.-2014ZA01151,CIPLA,"LIU K, FARAHANI M, MASHAMBA T, MAWELA M, JOSEPH J, VAN SCHAIK N, HONEY E, GILL M, JASSAT W, STRINGER E, CHINTU N, MARLINK R. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;00:1-10",,,I,,Y,,,20140828,N,OT,US,ZA,Efavirenz,Anomaly of external ear congenital;Maternal drugs affecting foetus,104144181,CA,,,,,,,,,,,
10415427,104154271,1,I,,20140818,20140828,20140828,EXP,,US-CIPLA LTD.-2014ZA01153,CIPLA,"LIU K, FARAHANI M, MASHAMBA T, MAWELA M, JOSEPH J, VAN SCHAIK N, HONEY E, GILL M, JASSAT W, STRINGER E, CHINTU N, MARLINK R. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;00:1-10",,,I,,Y,,,20140828,N,OT,US,ZA,Efavirenz,Dysmorphism,104154271,CA,,,,,,,,,,,
10415483,104154831,1,I,,20140818,20140828,20140828,EXP,,US-CIPLA LTD.-2014ZA01154,CIPLA,"LIU K, FARAHANI M, MASHAMBA T, MAWELA M, JOSEPH J, VAN SCHAIK N, HONEY E, GILL M, JASSAT W, STRINGER E, CHINTU N, MARLINK R. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;00:1-10",,,I,,Y,,,20140828,N,OT,US,ZA,Efavirenz,Congenital abdominal hernia;Foetal exposure during pregnancy,104154831,CA,,,,,,,,,,,
10415541,104155411,1,I,,20140818,20140828,20140828,EXP,,US-CIPLA LTD.-2014ZM01158,CIPLA,"MARLINK RG , LIU  KC, FARAHANI M ,MASHAMBA T , MAWELA M ,JOSEPH J ,SCHAIK V ,HONEY E , GILL M, JASSAT W , STRINGER EM ,CHINTU N .. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA.. AIDS. 2014;28:1 TO 10",,,,,Y,,,20140828,N,OT,US,ZM,Efavirenz,Foetal exposure during pregnancy;Hypospadias,104155411,CA,,,,,,,,,,,
10415707,104157071,1,I,,20140819,20140828,20140828,EXP,,US-CIPLA LTD.-2014ZM01166,CIPLA,"K. CHERRY LIU, MANSOUR FARAHANI, TSHILILO MASHAMBA, MUTHUHADINI MAWELA, JESSICA JOSEPH, NIENKE VAN SCHAIK, ENGELA HONEY, MICHELLE GILL, WAASILA JASSAT, ELIZABETH M. STRINGER, NAMIWNGA CHINTU AND RICHA. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28",,,,,Y,,,20140828,N,OT,US,ZM,Efavirenz,Foetal exposure during pregnancy;Stillbirth,104157071,OT,,,,,,,,,104157071,1,HIV infection
10415833,104158331,1,I,,20140818,20140828,20140828,EXP,,US-CIPLA LTD.-2014ZA01168,CIPLA,"K. CHERRY LIU, MANSOUR FARAHANI, TSHILILO MASHAMBA, MUTHUHADINI MAWELA, JESSICA JOSEPH, NIENKE VAN SCHAIK, ENGELA HONEY, MICHELLE GILL, WAASILA JASSAT, ELIZABETH M. STRINGER, NAMIWNGA CHINTU AND RICHA. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28",,,N,,Y,,,20140828,N,OT,US,ZA,Efavirenz,Low birth weight baby,104158331,OT,,,,,,,,,,,
10415973,104159731,1,I,,20140819,20140828,20140828,EXP,,US-CIPLA LTD.-2014ZA01169,CIPLA,"K. CHERRY LIU, MANSOUR FARAHANI, TSHILILO MASHAMBA, MUTHUHADINI MAWELA, JESSICA JOSEPH, NIENKE VAN SCHAIK, ENGELA HONEY, MICHELLE GILL, WAASILA JASSAT, ELIZABETH M. STRINGER, NAMIWNGA CHINTU AND RICHA. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014",,,N,,Y,,,20140828,N,OT,US,ZA,Efavirenz,Neonatal disorder,104159731,DE,,,,,,,,,104159731,6,HIV infection
10415997,104159971,1,I,,20140819,20140828,20140828,EXP,,US-CIPLA LTD.-2014ZA01170,CIPLA,"K. CHERRY LIU, MANSOUR FARAHANI, TSHILILO MASHAMBA, MUTHUHADINI MAWELA, JESSICA JOSEPH, NIENKE VAN SCHAIK, ENGELA HONEY, MICHELLE GILL, WAASILA JASSAT, ELIZABETH M. STRINGER, NAMIWNGA CHINTU AND RICHA. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS 2014. 2014;28",,,I,,Y,,,20140828,N,OT,US,ZA,Efavirenz,Genitalia external ambiguous,104159971,CA,,,,,,,,,,,
10416236,104162361,1,I,,20130724,20140828,20140828,EXP,,US-GILEAD-2013-0080143,GILEAD,,,,,M,Y,,,20140828,N,CN,US,US,SUSTIVA,Depression;Emotional distress;Gynaecomastia,,,,,104162361,1,2006,2006,,,104162361,1,HIV infection
10416273,104162731,1,I,,20131031,20140828,20140828,EXP,,US-GILEAD-2013-0086862,GILEAD,,40,YR,A,M,Y,,,20140828,N,CN,US,US,EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,Abdominal pain upper;Decreased appetite;Dizziness,,,,,,,,,,,104162731,1,HIV infection
10417473,104174731,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01188,CIPLA,"K LIU, MANSOUR FARAHANI, TSHILILO MASHAMBA, MUTHUHADINI MAWELA, JESSICA JOSEPH, NIENKE SCHAIK, ENGELA HONEY, MICHELLE GILL, WAASILA JASSAT, ELIZABETH STRINGER, NAMIWNGA CHINTU, RICHARD MARLINK. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014",,,,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Haemorrhage in pregnancy,104174731,OT,,,,,,,,,104174731,1,HIV infection
10417541,104175411,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01189,CIPLA,"K LIU, MANSOUR FARAHANI, TSHILILO MASHAMBA, MUTHUHADINI MAWELA, JESSICA JOSEPH, NIENKE SCHAIK, ENGELA HONEY, MICHELLE GILL, WAASILA JASSAT, ELIZABETH STRINGER, NAMIWNGA CHINTU, RICHARD MARLINK. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014",,,,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Foetal malpresentation,104175411,OT,,,,,,,,,104175411,1,HIV infection
10417544,104175441,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01191,CIPLA,"K LIU, MANSOUR FARAHANI, TSHILILO MASHAMBA, MUTHUHADINI MAWELA, JESSICA JOSEPH, NIENKE SCHAIK, ENGELA HONEY, MICHELLE GILL, WAASILA JASSAT, ELIZABETH STRINGER, NAMIWNGA CHINTU, RICHARD MARLINK. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014",,,,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Placenta praevia,104175441,OT,,,,,,,,,104175441,1,HIV infection
10417561,104175611,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01160,CIPLA,"MARLINK RG , LIU  KC, FARAHANI M ,MASHAMBA T , MAWELA M ,JOSEPH J ,SCHAIK V ,HONEY E , GILL M, JASSAT W , STRINGER EM ,CHINTU N .. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28:01 TO 10",,,,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Congenital optic nerve anomaly,104175611,CA,,,,,,,,,,,
10417563,104175631,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01161,CIPLA,"MARLINK RG , LIU  KC, FARAHANI M ,MASHAMBA T , MAWELA M ,JOSEPH J ,SCHAIK V ,HONEY E , GILL M, JASSAT W , STRINGER EM ,CHINTU N .. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA.. AIDS. 2014;28:01 TO 10",,,,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Atrial septal defect,104175631,CA,,,,,,,,,,,
10417565,104175651,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZM01162,CIPLA,"MARLINK RG , LIU  KC, FARAHANI M ,MASHAMBA T , MAWELA M ,JOSEPH J ,SCHAIK V ,HONEY E , GILL M, JASSAT W , STRINGER EM ,CHINTU N .. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA.. AIDS. 2014;28:01 TO 10",,,,,Y,,,20140829,N,OT,US,ZM,Efavirenz,Plagiocephaly,104175651,CA,,,,,,,,,,,
10417572,104175721,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01163,CIPLA,"MARLINK RG , LIU  KC, FARAHANI M ,MASHAMBA T , MAWELA M ,JOSEPH J ,SCHAIK V ,HONEY E , GILL M, JASSAT W , STRINGER EM ,CHINTU N .. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28:01 TO 10",,,,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Atrial septal defect,104175721,CA,,,,,,,,,,,
10417581,104175811,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01182,CIPLA,"LIUKC,FARAHANIM,MASHAMBAT,MAWELAM,JOSEPHJ,SCHAIKNV,HONEYE,GILLM,JASSATW,STRINGEREM,CHINTUN,MARLINKRG. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28",,,I,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Talipes,104175811,CA,,,,,,,,,,,
10417589,104175891,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01186,CIPLA,"LIUKC,FARAHANIM,MASHAMBAT,MAWELAM,JOSEPHJ,SCHAIKNV,HONEYE,GILLM,JASSATW,STRINGEREM,CHINTUN,MARLINKRG. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28",,,I,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Blepharophimosis;Eyelid ptosis,104175891,CA,,,,,,,,,,,
10417608,104176081,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01187,CIPLA,"LIU K C, FARAHANI M, MASHAMBA T, MAWELA M,JOSEPH J, SCHAIK NV, HONEY E, GILL M,JASSAT W,STRINGER EM,CHINTU N,MARLINK RG. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28",,,I,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Cleft lip,104176081,CA,,,,,,,,,,,
10417618,104176181,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01190,CIPLA,"LIU KC,FARAHANI M, MASHAMBA T,MAWELA M, JOSEPH J,SCHAIK NV,HONEY E,GILL M,JASSAT W,STRINGER EM,CHINTU N,MARLINK RG. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28",,,I,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Joint hyperextension,104176181,CA,,,,,,,,,,,
10417633,104176331,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01192,CIPLA,"LIU KC,FARAHANI M, MASHAMBA T,MAWELA M,JOSEPH J ,SCHAIK NV,HONEY E,GILL M,JASSAT W,STRINGER EM,CHINTU N,MARLINK RG. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28",,,I,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Foetal exposure during pregnancy;Hypospadias,104176331,CA,,,,,,,,,,,
10417687,104176871,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01171,CIPLA,"MARLINK RG, LIU KC, FARAHANI M, MASHAMBA T, MAWELA M, JOSEPH J ET.AL.. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28:1-10",,,,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Syndactyly,104176871,CA,,,,,,,,,,,
10417708,104177081,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01172,CIPLA,"MARLINK RG, LIU KC, FARAHANI M, MASHAMBA T, MAWELA M, JOSEPH J ET.AL.. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28:1-10",,,,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Atrophy;Macrocephaly;Ventricular septal defect,104177081,CA,,,,,,,,,,,
10417714,104177141,1,I,,20140818,20140829,20140829,EXP,,ZA-CIPLA LTD.-2014ZA01173,CIPLA,"MARLINK RG, LIU KC, FARAHANI M, MASHAMBA T, MAWELA M, JOSEPH J ET.AL.. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28:1-10",,,,,Y,,,20140829,N,OT,ZA,ZA,Efavirenz,Congenital skin disorder,104177141,CA,,,,,,,,,,,
10417749,104177491,1,I,,20140818,20140829,20140829,EXP,,US-CIPLA LTD.-2014ZA01174,CIPLA,"MARLINK RG, LIU KC, FARAHANI M, MASHAMBA T, MAWELA M, JOSEPH J ET.AL.. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28:1-10",,,,,Y,,,20140829,N,OT,US,ZA,Efavirenz,Polydactyly,104177491,CA,,,,,,,,,,,
10418455,104184551,1,I,,20131010,20140829,20140829,PER,,US-VIIV HEALTHCARE LIMITED-A1045270A,GLAXOSMITHKLINE,,,,,,Y,,,20140829,N,CN,US,US,SUSTIVA,Amnesia;Anxiety;Paraesthesia,,,,,,,,,,,104184551,1,Product used for unknown indication
10418598,104185981,1,I,,20140812,20140827,20140827,EXP,,2014HINLIT0729,HETERO,,29,YR,,F,N,,,20140825,N,MD,JP,,EFAVIRENZ,Microcytic anaemia;Pancytopenia,104185981,HO,104185981,HP,,,,,,,104185981,1,HIV infection
10419711,104197111,1,I,2014,20140815,20140829,20140829,EXP,,KE-BRISTOL-MYERS SQUIBB COMPANY-21316997,BRISTOL MYERS SQUIBB,,25,YR,,F,Y,,,20140829,N,CN,KE,KE,EFAVIRENZ,Cachexia;Dehydration;Diarrhoea;Meningitis;Oral candidiasis;Pulmonary tuberculosis;Sepsis;Thrombocytopenia,104197111,DE,,,104197111,1,20140630,20140729,,,104197111,1,HIV infection
10419764,104197643,3,F,20140703,20140814,20140829,20140922,EXP,,HT-BRISTOL-MYERS SQUIBB COMPANY-21190731,BRISTOL MYERS SQUIBB,,33,YR,,M,Y,,,20140922,N,CN,HT,HT,EFAVIRENZ,Anaemia;Respiratory tract infection;Sepsis,104197643,OT,,,104197643,1,20130905,20140703,,,104197643,4,Antifungal prophylaxis
10420089,104200891,1,I,,20140818,20140828,20140828,EXP,,2014ZM01152,CIPLA,,,,,,N,,,20140826,N,,ZM,,EFAVIRENZ (EFAVIRENZ),Maternal drugs affecting foetus;Strabismus congenital,104200891,CA,104200891,HP,,,,,,,,,
10421024,104210241,1,I,,20140819,20140828,20140828,EXP,,2014ZA01167,CIPLA,,,,,F,N,,,20140826,N,,ZA,,EFAVIRENZ,Ectopic pregnancy;Exposure during pregnancy,104210241,OT,104210241,FGN,,,,,,,104210241,1,HIV infection
10421977,104219771,1,I,,20140821,20140901,20140901,EXP,,CM-AUROBINDO-AUR-APL-2014-09186,AUROBINDO,,30,YR,,M,Y,65,KG,20140901,N,OT,GB,CM,EFAVIRENZ,Paradoxical drug reaction,104219771,HO,,,104219771,1,20130119,20130303,,,104219771,1,Retroviral infection
10422123,104221231,1,I,,20140818,20140901,20140901,EXP,,ZM-CIPLA LTD.-2014ZM01175,CIPLA,"MARLINK RG, LIU KC, FARAHANI M, MASHAMBA T, MAWELA M, JOSEPH J ET.AL.. PREGNANCY OUTCOMES AND BIRTH DEFECTS FROM AN ANTIRETROVIRAL DRUG SAFETY STUDY OF WOMEN IN SOUTH AFRICA AND ZAMBIA. AIDS. 2014;28:1-10",,,,,Y,,,20140901,N,OT,ZM,ZM,Efavirenz,Congenital abdominal hernia,104221231,CA,,,,,,,,,,,
10427314,104273141,1,I,,20140826,20140903,20140903,EXP,,PHHY2014US106841,SANDOZ,"CIRCO S, DILLARD T, DAVIS W. ENDOBRONCHIAL MASS DUE TO MAC INFECTION DESPITE MACROLIDE PROPHYLAXIS. CHEST. 2013;144(4):1-2",38,YR,,F,Y,,,20140903,N,OT,US,US,EFAVIRENZ,Cough;Dyspnoea;Excessive granulation tissue;Haemoptysis;Immune reconstitution inflammatory syndrome;Lung infiltration;Mycobacterium avium complex infection;Tracheal mass,104273141,OT,,,,,,,,,104273141,1,HIV infection
10428439,104284392,2,F,20140417,20140904,20140903,20140908,EXP,,HR-VIIV HEALTHCARE LIMITED-B1029242A,GLAXOSMITHKLINE,,42,YR,,M,Y,,,20140908,N,OT,HR,HR,EFAVIRENZ,Myocardial infarction,104284392,HO,,,104284392,1,20091116,20140427,,,104284392,1,HIV infection
10428443,104284431,1,I,,20140826,20140903,20140903,EXP,,ZA-VIIV HEALTHCARE LIMITED-B1029321A,GLAXOSMITHKLINE,"MAZANDERANI AF, PLESSIS NM, THOMAS WN, VENTER E, AVENANT T. LOSS OF DETECTABILITY AND INDETERMINATE RESULTS: CHALLENGES FACING HIV INFANT DIAGNOSIS IN SOUTH AFRICA^S EXPANDING ART PROGRAMME. SAMJ. 2014; 104 (8): 574-577.",,,I,,Y,,,20140903,N,MD,ZA,ZA,EFAVIRENZ,Empyema;Exposure during breast feeding;Foetal exposure during pregnancy;HIV infection;Lower respiratory tract infection,104284431,OT,,,,,,,,,104284431,1,HIV infection
10433671,104336711,1,I,,20140827,20140905,20140905,EXP,,PHHY2014NL110383,NOVARTIS,"BURGER DM, AVIHINGSANON A, RAMAUTARSING RA, SUWANPIMOLKUL G, CHETCHOTISAKD P JIRAJARIYAVEJ S, ET AL. ERGOTISM IN THAILAND CAUSED BY INCREASED ACCESS TO ANTIRETROVIRAL DRUGS: A GLOBAL WARNING. TOPICS IN ANTIVIRAL MEDICINE. 2014;21 (5):165-168",,,,F,Y,,,20140905,N,OT,NL,NL,EFAVIRENZ,Drug interaction;Ergot poisoning;Hypotension;Peripheral ischaemia,104336711,HO,,,,,,,,,,,
10434353,104343532,2,F,20140823,20140917,20140905,20140924,EXP,,MW-009507513-1409MWI002261,MERCK,,49,YR,,M,Y,,,20140924,N,CN,US,MW,EFAVIRENZ,Immune reconstitution inflammatory syndrome;Lower respiratory tract infection,104343532,DE,,,104343532,1,20140714,20140823,,,104343532,1,HIV infection
10434549,104345492,2,F,20140823,20140904,20140905,20140909,EXP,,MW-GILEAD-2014-0114119,GILEAD,,26,YR,A,F,Y,,,20140909,N,MD,MW,MW,EFAVIRENZ,Meningitis cryptococcal,104345492,OT,,,104345492,1,20140821,20140829,,,104345492,1,HIV infection
10445017,104450171,1,I,,20140901,20140910,20140910,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-21372230,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20140910,N,CN,US,DE,SUSTIVA,Anal cancer,104450171,OT,,,,,,,,,104450171,1,HIV infection
10446690,104466902,2,F,,20140911,20140911,20140919,EXP,,ZA-AUROBINDO-AUR-APL-2014-09342,AUROBINDO,"DU TOIT SH, ET AL. IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME. REACTIONS WEEKLY. 2014;1516:83",40,YR,,M,Y,,,20140919,N,OT,ZA,ZA,Efavirenz,Conjunctival hyperaemia;Corneal lesion;Eye pain;Immune reconstitution inflammatory syndrome;Ulcerative keratitis,104466902,OT,,,,,,,,,104466902,1,HIV infection
10449138,104491382,2,F,20140818,20140905,20140912,20140919,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-21366067,BRISTOL MYERS SQUIBB,,34,YR,,M,Y,51.8,KG,20140919,N,CN,ZA,ZA,EFAVIRENZ,Headache,104491382,HO,,,104491382,1,20131118,,,,104491382,1,HIV infection
10452904,104529043,3,F,20090515,20140911,20140915,20140918,EXP,,FR-SANOFI-AVENTIS-200912857FR,AVENTIS,,37,YR,A,F,Y,,,20140918,N,OT,FR,FR,SUSTIVA,Cholestasis;Hepatitis fulminant;Hepatocellular injury;Jaundice;Lactic acidosis;Tachypnoea,104529043,LT,,,104529043,1,20090503,20090516,,,104529043,1,Disseminated tuberculosis
10453226,104532261,1,I,20140823,20140902,20140915,20140915,EXP,,MW-BRISTOL-MYERS SQUIBB COMPANY-21366125,BRISTOL MYERS SQUIBB,,49,YR,,M,Y,,,20140915,N,CN,US,MW,EFAVIRENZ,Asthenia;Chills;Cough;Dyspnoea;Immune reconstitution inflammatory syndrome;Lower respiratory tract infection;Pneumonia;Pyrexia,104532261,OT,,,104532261,1,20140714,20140823,,,104532261,1,HIV infection
10453387,104533871,1,I,,20140904,20140915,20140915,EXP,,PHHY2014CM115749,SANDOZ,"WANDA F, NKEMENANG P, EHOUNOU G, TCHATON M, COMTE E, TOUTOUS TRELLU L, ET AL.. CLINICAL FEATURES AND MANAGEMENT OF A SEVERE PARADOXICAL REACTION ASSOCIATED WITH COMBINED TREATMENT OF BURULI ULCER AND HIV CO-INFECTION. BMC-INFECT-DIS. 2014;14(1)",30,YR,,M,Y,65,KG,20140915,N,OT,AU,CM,EFAVIRENZ,Dermatitis;Granuloma;Oedema peripheral;Paradoxical drug reaction;Skin lesion;Skin necrosis;Skin ulcer,104533871,HO,,,104533871,1,20130109,20130303,,,104533871,1,Mycobacterium ulcerans infection
10457021,104570211,1,I,2013,20140902,20140912,20140912,EXP,,2014VER00207,VERSAPHARM,,30,YR,,M,N,65,KG,20140911,N,OT,CM,,EFAVIRENZ,Paradoxical drug reaction;Skin ulcer;Wound necrosis,104570211,OT,104570211,FGN,104570211,1,20130109,20130303,,,104570211,1,Mycobacterium ulcerans infection
10457080,104570801,1,I,,20140902,20140912,20140912,EXP,,2014HINLIT0797,HETERO,,,,,F,N,,,20140911,N,MD,TH,,EFAVIRENZ (EFAVIRENZ) UNKNOWN,Drug interaction;Ergot poisoning,104570801,LT,104570801,LIT,,,,,,,104570801,1,HIV infection
10457144,104571442,2,F,20140823,20140911,20140916,20140922,EXP,,BW-GILEAD-2014-0114939,GILEAD,,31,YR,A,F,Y,,,20140922,N,MD,BW,BW,EFAVIRENZ,Abortion spontaneous,104571442,OT,,,104571442,1,20110624,20140806,,,104571442,1,HIV infection
10457283,104572831,1,I,20140630,20140909,20140916,20140916,EXP,,MW-GILEAD-2014-0114855,GILEAD,,36,YR,A,M,Y,48.7,KG,20140916,N,MD,MW,MW,EFAVIRENZ,Jaundice,104572831,OT,,,104572831,1,20140616,20140630,,,104572831,1,HIV infection
10457439,104574391,1,I,,20140904,20140916,20140916,EXP,,CM-BRISTOL-MYERS SQUIBB COMPANY-21389077,BRISTOL MYERS SQUIBB,,30,YR,,M,Y,,,20140916,N,OT,AU,CM,EFAVIRENZ,Paradoxical drug reaction,104574391,HO,,,104574391,1,20130119,,,,104574391,1,HIV infection
10458852,104588521,1,I,,20140904,20140917,20140917,EXP,,CM-MYLANLABS-2014M1004564,MYLAN,"WANDA F, NKEMENANG P, EHOUNOU G, TCHATON M, COMTE E, TOUTOUS TRELLU L, ET AL. CLINICAL FEATURES AND MANAGEMENT OF A SEVERE PARADOXICAL REACTION ASSOCIATED WITH COMBINED TREATMENT OF BURULI ULCER AND HIV CO-INFECTION. BMC-INFECT-DIS 2014;",,,,,Y,,,20140917,N,OT,CM,CM,EFAVIRENZ,Hypersensitivity;Oedema peripheral;Paradoxical drug reaction;Pyrexia;Rash pruritic;Rash pustular;Skin graft;Skin necrosis;Wound necrosis,104588521,HO,104588521,HP,104588521,1,20130119,,,,104588521,1,HIV infection
10458953,104589531,1,I,,20140903,20140917,20140917,EXP,,GB-MYLAN-2014M1003750,MYLAN,"BOXALL E., MILNE J., PETERS E., SYKES C.. SUDDEN UNEXPLAINED DEATH IN A PATIENT WITH HIV AND MDR-TB. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY.. 2010",,,,,Y,,,20140917,N,OT,GB,GB,EFAVIRENZ,Arrhythmia;Oral candidiasis,104589531,DE,,,,,,,,,104589531,2,Oral candidiasis
10459347,104593471,1,I,,20140909,20140917,20140917,EXP,,TH-GILEAD-2014-0115442,GILEAD,"PORNPRASERT S, WONGNOI R, OBERDORFER P, SIRIVATANAPA P. PREVENTIVE ANTIRETROVIRAL THERAPY IN NON-THALASSEMIA CARRIER INFANTS EXPOSED TO MOTHER-TO-CHILD TRANSMISSION OF HIV DECREASES CORD AND AFTER DELIVERY RED BLOOD PRODUCTION WITHOUT ALTERING THE DEVELOPMENT OF HEMOGLOBIN.. CURRENT HIV RESEARCH. 2014;12(3):227-231",,,I,,Y,,,20140917,N,OT,TH,TH,EFAVIRENZ,Anaemia,104593471,OT,,,,,,,,,104593471,1,HIV infection
10460363,104603631,1,I,20140612,20140908,20140917,20140917,EXP,,CI-GILEAD-2014-0114750,GILEAD,,36,YR,A,F,Y,54,KG,20140917,N,MD,CI,CI,EFAVIRENZ,Hypercreatinaemia,104603631,OT,,,104603631,1,201407,20131202,,,104603631,1,HIV infection
10465485,104654851,1,I,20140911,20140915,20140919,20140919,EXP,,KE-GILEAD-2014-0115417,GILEAD,,36,YR,A,M,Y,,,20140919,N,MD,KE,KE,EFAVIRENZ,Alanine aminotransferase increased;Anaemia;Aspartate aminotransferase increased;Bedridden;Blood bilirubin increased;Blood sodium decreased;Body temperature decreased;Cachexia;Dehydration;Diet refusal;Dyspnoea;General physical health deterioration;Hypoglycaemia;Hypovolaemic shock;Malnutrition;Oedema;Oesophageal candidiasis;Oral candidiasis;Pallor;Peripheral coldness;Pulmonary tuberculosis;Renal failure;Renal failure acute,104654851,HO,,,104654851,1,20140819,20140910,,,104654851,1,HIV infection
10467125,104671251,1,I,20140825,20140916,20140922,20140922,EXP,,BW-GILEAD-2014-0115655,GILEAD,,32,YR,A,F,Y,,,20140922,N,OT,BW,BW,EFAVIRENZ,Abortion spontaneous,104671251,OT,,,104671251,1,20110609,20140806,,,104671251,1,HIV infection
10467423,104674232,2,F,,20140131,20140922,20140922,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-19958636,BRISTOL MYERS SQUIBB,,,,,,Y,,,20140922,N,CN,US,FR,SUSTIVA,Ascites;Foetal exposure during pregnancy;Pulmonary hypoplasia;Stillbirth,104674232,DE,,,,,,,,,,,
10467464,104674642,2,F,20140825,20140919,20140922,20140924,EXP,,BW-BRISTOL-MYERS SQUIBB COMPANY-21415971,BRISTOL MYERS SQUIBB,,32,YR,,F,Y,,,20140924,N,CN,US,BW,EFAVIRENZ,Abortion spontaneous;Maternal exposure during pregnancy,104674642,OT,,,104674642,1,20110609,20140904,,,104674642,1,Antiretroviral therapy
10468955,104689552,2,F,20090515,20140909,20140923,20140923,EXP,,FR-MERCK-1408FRA002993,MERCK,,37,YR,,F,Y,,,20140923,N,MD,FR,FR,SUSTIVA,Hepatitis fulminant,104689552,LT,,,104689552,1,20090503,20090516,,,104689552,1,HIV infection
10470790,104707901,1,I,,20140915,20140923,20140923,EXP,,IN-VIIV HEALTHCARE LIMITED-B1035121A,GLAXOSMITHKLINE,"KRISHNARAJ R, ET AL. RECURRENT IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME OF TUBERCULOUS BRAIN INFECTION IN PEOPLE LIVING WITH HIV/AIDS: A CASE REPORT. JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE  2014; 13 (1): 15-17.",41,YR,,M,Y,,,20140923,N,MD,IN,IN,EFAVIRENZ,Abnormal behaviour;Brain abscess;Dysarthria;Headache;Hemiparesis;Loss of consciousness;Meningitis tuberculous,104707901,HO,,,,,,,,,104707901,1,HIV infection
10470801,104708012,2,F,20140528,20140925,20140923,20140925,EXP,,DE-VIIV HEALTHCARE LIMITED-D0085528A,GLAXOSMITHKLINE,,52,YR,,M,Y,95,KG,20140925,N,OT,DE,DE,SUSTIVA,Adenocarcinoma of colon;Colectomy;Colon cancer;Enterostomy;Gastroenteritis shigella;Incorrect dosage administered;Intestinal ischaemia,104708012,DS,,,104708012,1,1999,2014,,,104708012,1,HIV infection
10471306,104713061,1,I,20140721,20140909,20140923,20140923,EXP,,MW-009507513-1409MWI010789,MERCK,,35,YR,,M,Y,,,20140923,N,CN,US,MW,EFAVIRENZ,Pleural effusion;Pneumonia,104713061,OT,,,104713061,1,20140717,,,,104713061,1,HIV infection
10475669,104756691,1,I,20140825,20140916,20140925,20140925,EXP,,BW-ABBVIE-14P-019-1285352-00,ABBVIE,,32,YR,,F,Y,,,20140925,N,MD,COUNTRY NOT SPECIFIED,BW,EFAVIRENZ,Abortion spontaneous,104756691,OT,,,104756691,1,20140806,20140806,,,104756691,1,HIV infection
10476477,104764771,1,I,,20140923,20140925,20140925,EXP,,CO-VIIV HEALTHCARE LIMITED-A1090931A,GLAXOSMITHKLINE,,29,YR,,M,Y,,,20140925,N,OT,CO,CO,EFAVIRENZ,Drug hypersensitivity;Local swelling;Malaise;Oedema;Rash,104764771,HO,,,,,,,,,104764771,1,HIV infection
10476531,104765311,1,I,,20140922,20140925,20140925,EXP,,UG-VIIV HEALTHCARE LIMITED-B1036950A,GLAXOSMITHKLINE,"VELAMAKANNI SS, BAHR NC, MUSUBIRE AK, BOULWARE DR, RHEIN J, NABETA HW. CENTRAL NERVOUS SYSTEM CRYPTOCOCCOMA IN A UGANDAN PATIENT WITH HUMAN IMMUNODEFICIENCY VIRUS. MEDICAL MYCOLOGY CASE REPORTS. 2014; 6: 10-13.?",45,YR,,M,Y,,,20140925,N,MD,UG,UG,EFAVIRENZ,Anaemia;Asthenia;Cryptococcosis;Decreased appetite;Dehydration;Generalised tonic-clonic seizure;Hemiparesis;Immune reconstitution inflammatory syndrome;Lethargy;Lymphadenopathy;Pneumonia aspiration;Renal failure,104765311,DE,,,,,,,,,104765311,1,HIV infection
10477391,104773911,1,I,2013,20140912,20140926,20140926,EXP,,CM-RANBAXY-2014RR-85600,RANBAXY,,30,YR,,M,Y,65,KG,20140926,N,OT,CM,CM,Efavirenz,Hypersensitivity;Paradoxical drug reaction,104773911,HO,,,104773911,1,201301,20130303,,,104773911,1,Mycobacterium ulcerans infection
10478738,104787381,1,I,,20140911,20140926,20140926,EXP,,TH-WATSON-2014-20594,WATSON,"AVIHINGSANON A, RAMAUTARSING RA, SUWANPIMOLKUL G, CHETCHOTISAKD P ET ALL. ERGOTISM IN THAILAND CAUSED BY INCREASED ACCESS TO ANTIRETROVIRAL DRUGS: A GLOBAL WARNING. TOP ANTIVIR MED. 2014;21(5):165-8",38,YR,,F,Y,,,20140926,N,MD,TH,TH,EFAVIRENZ,Drug interaction;Ergot poisoning;Hypoaesthesia;Nausea;Paraesthesia;Pulse abnormal;Vomiting,104787381,HO,,,,,,,,,104787381,1,Migraine
10478742,104787421,1,I,,20140911,20140926,20140926,EXP,,TH-WATSON-2014-20603,WATSON,"AVIHINGSANON A, RAMAUTARSING RA, SUWANPIMOLKUL G, CHETCHOTISAKD P ET ALL. ERGOTISM IN THAILAND CAUSED BY INCREASED ACCESS TO ANTIRETROVIRAL DRUGS: A GLOBAL WARNING. TOP ANTIVIR MED. 2014;21(5):165-8",,,,F,Y,,,20140926,N,MD,TH,TH,Efavirenz (Unknown),Drug interaction;Ergot poisoning,104787421,OT,,,,,,,,,104787421,1,Migraine
10479608,104796081,1,I,,20140909,20140925,20140925,EXP,,2014HINLIT0827,HETERO,,11,YR,,F,N,,,20140924,N,MD,US,,EFV (EFAVIRENZ) (EFV (EFAVIRENZ)),Cushing's syndrome;Drug interaction,104796081,OT,104796081,LIT,,,,,,,104796081,1,HIV infection
10480491,104804911,1,I,,20140909,20140925,20140925,EXP,,2014HINLIT0848,HETERO,,45,YR,,M,N,,,20140924,N,MD,US,,EFAVIRENZ (EFAVIRENZ) UNKNOWN,Abdominal distension;CD4 lymphocytes decreased;Cushing's syndrome;Drug interaction,104804911,OT,104804911,HP,104804911,4,,,20,DAY,104804911,1,HIV infection
10480643,104806431,1,I,20140318,20140729,20140925,20140925,EXP,,KAD201409-001098,KADMON,,67,YR,,M,N,62,KG,20140922,N,OT,GB,,EFAVIRENZ (EFAVIRENZ),Abscess;Acute generalised exanthematous pustulosis;Blister;Off label use,104806431,OT,104806431,HP,104806431,1,20140124,20140711,,,104806431,1,Hepatitis C
10480694,104806941,1,I,,20140909,20140925,20140925,EXP,,2014HINLIT0833,HETERO,,16,YR,,F,N,,,20140924,N,MD,US,,EFV (EFAVIRENZ),Cushing's syndrome;Drug interaction,104806941,OT,104806941,LIT,104806941,4,,,91,DAY,104806941,1,HIV infection
10480720,104807201,1,I,,20140909,20140925,20140925,EXP,,2014HINLIT0828,HETERO,,12,YR,,F,N,,,20140924,N,MD,US,,EFV (EFAVIRENZ),Abdominal pain upper;Contusion;Decreased appetite;Diarrhoea;Drug interaction;Hirsutism;Livedo reticularis;Malaise;Nausea;Skin striae;Vomiting;Waist circumference increased;Weight increased,104807201,HO,104807201,HP,104807201,4,,,60,DAY,104807201,1,HIV infection
10482741,104827411,1,I,20140828,20140922,20140929,20140929,EXP,,KE-GILEAD-2014-0116423,GILEAD,,42,YR,A,F,Y,,,20140929,N,MD,KE,KE,EFAVIRENZ,Anaemia;Extrapulmonary tuberculosis;Liver abscess;Oesophageal candidiasis,104827411,OT,,,104827411,1,20140818,20140818,,,104827411,1,HIV infection
10484033,104840331,1,I,,20140909,20140926,20140926,EXP,,2014HINLIT0862,HETERO,,52,YR,,M,N,,,20140924,N,MD,US,,EFAVIRENZ (EFAVIRENZ) UNKNOWN,Blood glucose increased;CD4 lymphocytes decreased;Cushing's syndrome;Drug interaction;Dysphonia;Muscle spasms;Oral pain;Oropharyngeal candidiasis,104840331,OT,104840331,LIT,104840331,4,,,61,DAY,104840331,1,HIV infection
10484105,104841051,1,I,,20140909,20140926,20140926,EXP,,2014HINLIT0859,HETERO,,48,YR,,F,N,,,20140924,N,MD,US,,EFAVIRENZ,Cushing's syndrome;Drug interaction,104841051,OT,104841051,LIT,104841051,5,,,549,DAY,104841051,1,HIV infection
10484820,104848201,1,I,20140714,20140718,20140930,20140930,EXP,,KE-BRISTOL-MYERS SQUIBB COMPANY-21230750,BRISTOL MYERS SQUIBB,,36,YR,,M,Y,,,20140930,N,OT,KE,KE,EFAVIRENZ,Anaemia;Drug resistance;Pneumonia,104848201,OT,,,104848201,1,20130910,20140421,,,104848201,1,Antiretroviral therapy
7074617,70746173,3,F,20090510,20140910,20090806,20140915,EXP,,FR-GILEAD-2009-0023412,GILEAD,,37,YR,A,F,Y,,,20140915,N,OT,FR,FR,SUSTIVA,Cholangitis;Granulomatous liver disease;Hepatitis fulminant;Immune reconstitution inflammatory syndrome,70746173,LT,,,70746173,1,20090503,20090516,,,70746173,1,HIV infection
7108363,71083635,5,F,20090812,20140714,20090909,20140729,EXP,,GB-RANBAXY-2009RR-27519,RANBAXY,,32,YR,,F,Y,68,KG,20140729,N,OT,GB,GB,Efavirenz,Abortion missed;Pregnancy,71083635,OT,,,71083635,1,20030429,20090804,,,71083635,1,Antiviral prophylaxis
7147274,71472743,3,F,20090515,20140910,20091013,20140922,EXP,,FR-ROCHE-660784,ROCHE,,36,YR,,F,Y,,,20140922,N,MD,FR,FR,SUSTIVA,Hepatitis fulminant,71472743,LT,,,71472743,1,20090503,20090516,,,71472743,1,HIV test positive
8631944,86319442,2,F,,20140717,20120625,20140801,EXP,,FR-RANBAXY-2012R1-57179,RANBAXY,,58,YR,,M,Y,48,KG,20140801,N,OT,FR,FR,Efavirenz,Ascites;Gynaecomastia;Lipodystrophy acquired;Nodular regenerative hyperplasia;Osteoporosis;Portal hypertension;Portal vein thrombosis;Protein-losing gastroenteropathy;Varices oesophageal,86319442,HO,,,,,,,,,86319442,1,HIV infection
9113290,91132903,3,F,20090511,20140909,20130211,20140911,EXP,,FR-009507513-0908FRA00027,MERCK,,36,YR,,F,Y,,,20140911,N,CN,US,FR,SUSTIVA,Cholestasis;Granulomatous liver disease;Hepatic encephalopathy;Hepatitis fulminant;Immune reconstitution inflammatory syndrome;Insomnia;Jaundice;Off label use;Tachypnoea;Tuberculosis liver,91132903,LT,,,91132903,1,20090511,20090516,,,91132903,1,Immune reconstitution inflammatory syndrome
9146626,91466263,3,F,20121123,20140717,20130307,20140718,EXP,,DE-ROCHE-1167466,ROCHE,,46,YR,,M,Y,90,KG,20140718,N,MD,DE,DE,EFAVIRENZ,Mental impairment,91466263,OT,,,91466263,1,20120305,20120813,,,91466263,1,Chronic hepatitis C
9252649,92526495,5,F,20120803,20140822,20130424,20140827,EXP,,CO-VIIV HEALTHCARE LIMITED-A1020794A,GLAXOSMITHKLINE,,28,YR,,M,Y,,,20140827,N,OT,CO,CO,EFAVIRENZ,Depression;Lipodystrophy acquired,92526495,OT,,,92526495,2,20120803,20130312,,,92526495,1,HIV infection
9261293,92612932,2,F,,20140722,20130429,20140725,EXP,,ZA-VIIV HEALTHCARE LIMITED-B0842972A,GLAXOSMITHKLINE,VAN TOORN R ET AL. NEUROLOGICAL MAINFESTAIONS OF TB-IRIS: A REPORT OF 4 CHILDREN. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY 2012; 16: 676-682.?,12,YR,,M,Y,,,20140725,N,MD,ZA,ZA,EFAVIRENZ,Cerebellar syndrome;Headache;Hydrocephalus;Immune reconstitution inflammatory syndrome associated tuberculosis;Intention tremor;Intracranial pressure increased;Papilloedema;Somnolence;Stevens-Johnson syndrome;Vomiting,92612932,HO,,,,,,,,,92612932,1,Antiviral treatment
9291577,92915772,2,F,201202,20140715,20130515,20140721,EXP,,FR-VIIV HEALTHCARE LIMITED-B0889823A,GLAXOSMITHKLINE,,51,YR,,M,Y,,,20140721,N,MD,FR,FR,SUSTIVA,Amyotrophy;Axonal neuropathy;Hypokinesia;Muscular weakness;Myalgia,92915772,DS,,,92915772,1,2005,20111102,,,92915772,1,HIV infection
9296378,92963782,2,F,201202,20140715,20130517,20140723,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-18889139,BRISTOL MYERS SQUIBB,,51,YR,,M,Y,,,20140723,N,CN,FR,FR,SUSTIVA,Amyotrophy;Axonal neuropathy,92963782,DS,,,92963782,1,2005,,,,92963782,1,HIV infection
9410395,94103955,5,F,,20140910,20130719,20140916,EXP,,US-VIIV HEALTHCARE LIMITED-A1034012A,GLAXOSMITHKLINE,,53,YR,,M,Y,,,20140916,N,MD,US,US,SUSTIVA,Diabetes mellitus;Renal transplant;Therapy cessation;Visual acuity reduced,94103955,HO,,,94103955,1,20120417,,,,94103955,1,HIV infection
9543333,95433337,7,F,20130821,20140701,20130923,20140709,EXP,,KR-ABBVIE-13P-090-1148744-00,ABBVIE,,,,,F,Y,,,20140709,N,MD,COUNTRY NOT SPECIFIED,KR,EFAVIRENZ,AIDS related complication;Asthenia;Depressed mood;Hyponatraemia;Immunodeficiency;Nausea;Pancytopenia;Plantar erythema;Pneumonia;Pruritus;Pyrexia;Unevaluable event;Urinary tract infection;Vomiting,95433337,OT,,,95433337,1,20130819,20130904,,,95433337,1,HIV infection
9654861,96548612,2,F,20131010,20140827,20131029,20140904,EXP,,CI-GILEAD-2013-0086165,GILEAD,,37,YR,A,F,Y,,,20140904,N,MD,CI,CI,EFAVIRENZ,Abortion spontaneous,96548612,OT,,,96548612,1,20081020,,,,96548612,1,HIV infection
9804855,98048555,5,F,,20140826,20140108,20140908,EXP,,US-009507513-1401USA001791,MERCK,,38,YR,,F,Y,,,20140908,N,CN,US,US,EFAVIRENZ,Immune reconstitution inflammatory syndrome;Mycobacterium avium complex infection,98048555,HO,,,,,,,,,98048555,1,HIV infection
9828915,98289154,4,F,20131227,20140919,20140118,20140926,EXP,,TH-ABBVIE-14P-155-1190231-00,ABBVIE,,23,YR,,M,Y,56,KG,20140926,N,MD,COUNTRY NOT SPECIFIED,TH,EFAVIRENZ,Nephrotic syndrome,98289154,HO,,,98289154,1,20131225,20140102,,,98289154,1,HIV infection
9928792,99287923,3,F,,20140807,20140227,20140812,EXP,,US-PFIZER INC-2014054673,PFIZER,,53,YR,,M,Y,,,20140812,N,CN,US,US,SUSTIVA,Activities of daily living impaired,99287923,HO,,,99287923,2,20140804,,,,,,
